Latest / Decera Clinical Education Oncology Podcast
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting
In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspectives on the clinical implications of these data for patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML), including:
Abstract 6: Phase II PARADIGM trial of azacitidine and venetoclax vs conventional intensive chemotherapy for fit patients with newly diagnosed AML
Abstract 47: Phase I/II SAVE trial of revumenib plus decitabine/cedazuridine and venetoclax in the cohort of patients with newly diagnosed AML
Abstract 766: Phase…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.